Narsico, Rosemarie .
HRN: 11-32-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2022
METRONIDAZOLE 500MG (TAB)
07/18/2022
07/18/2022
ORAL
500mg Tab
TID
Thinly Meconium Stained Amniotic Fluid
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes